None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Gender: Male, Female Age: 45 years over (1) Individuals who have been adequately informed about the clinical trial and have voluntarily consented to participate (2) Individuals who can provide a blood sample within three month before or after a colonoscopy procedure (3) Adults aged 45 or above. (4) Samples from patients diagnosed with colorectal cancer who have not received cancer treatments such as surgery, chemotherapy, or radiation therapy. (5) Samples from individuals with confirmed advanced adenoma or serrated polyp presence. (6) Samples from individuals who do not have colorectal cancer, advanced adenoma, or serrated polyp (7) Samples from individuals diagnosed with cancers other than colorectal cancer.
Exclusion criteria
Exclusion criteria: (1) Vulnerable participants with intellectual disabilities or severe mental disorders will be excluded. (2) Individuals deemed unsuitable by the researchers' judgment will be excluded. (3) Samples with a history of receiving medication or treatment affecting immune function within the last 6 months will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of the effectiveness of the 'ONCOCHECKTM Colorectal Cancer’ through clinical sensitivity and specificity assessment | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation of correlation (consistency) with colonoscopy and biopsy results, which are standard criteria for colon cancer diagnosis | — |
Countries
Korea, Republic of
Contacts
Yonsei University Health System, Severance Hospital